Pt. | Age | Sex | Pathology findings | Stage | Radiotherapy | Dose | Cx | Cx start | Relapse site | Follow-up (month) | Status |
1 | 62 | M | mixed | ED | WP | 60 Gy/50fr. (HF) | P/E/I | Concurrent | - | 48.9 | NED |
2 | 44 | M | mixed | LD | SP + Bladder | 60 Gy/30fr. | P/E/I | Before RT | Brain | 33.0 | DOD |
3 | 71 | M | Pure | ED | WP + Bladder | 63 Gy/35fr. | P/E | Concurrent | - | 54.5 | NED |
4 | 68 | M | Pure | ED | WP + Bladder | 60 Gy/50fr. (HF) | C/E | Before RT | Liver, Plura, Brain | 11.8 | AWD |
5 | 83 | M | Pure | LD | Bladder | 60 Gy/30fr. | - | - | Pelvis, PALN, Lung | 25.4 | AWD |
6 | 77 | M | pure | LD | WP + Bladder | 60 Gy/50fr. (HF) | - | - | PALN | 4.1 | DOA |